European Journal of Pharmacology 1989-08-22

Glycine antagonist action of 1-aminocyclobutane-1-carboxylate (ACBC) in Xenopus oocytes injected with rat brain mRNA.

G B Watson, M A Bolanowski, M P Baganoff, C L Deppeler, T H Lanthorn

Index: Eur. J. Pharmacol. 167(2) , 291-4, (1989)

Full Text: HTML

Abstract

ACBC has been reported to have the binding profile of an antagonist at the glycine site of the NMDA receptor. In Xenopus oocytes injected with rat brain mRNA, we have confirmed the antagonist action of ACBC on NMDA responses. ACBC and HA-966, a known glycine antagonist, blocked NMDA responses in a non-competitive manner and blocked the potentiation of NMDA responses by glycine in a competitive manner. We conclude that ACBC blocks NMDA responses via a competitive interaction at the glycine modulatory site.

Related Compounds

  • 1-Aminocyclobutane...

Related Articles:

[Change in the level of 1-aminochloropropane-1-carbonic acid. Activity of a protein inhibitor of polygalacturonase, intensity of formation of oligouronides in apples during ripening and treatment with haloethane derivatives and aminoethoxyvinylglycine].

2003-01-01

[Prikl. Biokhim. Mikrobiol. 39(4) , 461-4, (2003)]

Ethylene biosynthesis: processing of a substrate analog supports a radical mechanism for the ethylene-forming enzyme.

1998-01-01

[Chem. Biol. 5(1) , 49-57, (1998)]

Dietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the rat.

1993-01-01

[Brain Res. Bull. 32(3) , 223-6, (1993)]

1-aminocyclobutane[11C]carboxylic acid, a potential tumor-seeking agent.

1979-10-01

[J. Nucl. Med. 20(10) , 1055-61, (1979)]

Tumor detection with 1-aminocyclopentane and 1-aminocyclobutane C-11-carboxylic acid using positron emission computerized tomography.

1981-06-01

[Clin. Nucl. Med. 6(6) , 249-52, (1981)]

More Articles...